Skip to content

Clinical trials

Phase 3 Neoplasm Metastasis trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 3 Country / region: Mexico Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20052
20062
20081
20092
20121
20132
20142
20171
20215
20227
20232
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting12
Recruiting5
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca10
Eli Lilly and Company6
AbbVie2
Celcuity Inc2
Hoffmann-La Roche2
Novartis Pharmaceuticals2
Cogent Biosciences, Inc.1
GlaxoSmithKline1
Janssen Research & Development, LLC1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis33
Breast Neoplasms15
Neoplasms6
Carcinoma, Non-Small-Cell Lung3
Bone Neoplasms2
Breast Diseases2
Carcinoma, Renal Cell2
Melanoma2
Neoplasms by Site2
Pain2

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.